Skip to main content
Clinical Trials/NL-OMON56189
NL-OMON56189RecruitingNot Applicable

Preoperative CT-imaging with patient-specific computer simulation in transcatheter aortic valve replacement: a randomized controlled trial. - GUIDE-TAVR

Sint Antonius Ziekenhuis0 sites354 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
354

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - Primary symptomatic severe aortic valve stenosis (defined as an aortic valve
  • area of <1.0cm2 and either a mean valve gradient of at least 40mmHg or a peak
  • velocity of at least 4.0 m/s)
  • - Accepted for TAVR, either by transfemoral, transsubclavian or transapical
  • access as determined by the Heart Team and additionally the dedicated TAVR-team.
  • - Plan to implant one of the following TAVR heart valves for which FEops
  • HEARTguide* is available:
  • o CoreValve*, Evolut* R, and Evolut* PRO and Evolut* PRO+ valves (Medtronic)
  • o ACURATE neo* Aortic Valve System (Boston Scientific) (ACURATE neo 2* will be
  • available for FHG later this year)
  • - Informed consent

Exclusion Criteria

  • - Previous surgical aortic valve replacement
  • - Permanent pacemaker at baseline
  • - Emergency procedure
  • - Poor CT image quality (disabling computer-simulation), for example because of
  • motion artifacts due to the presence of other implanted devices affecting the
  • region of interest
  • - Patient who did not agree to the informed consent and/or refused to
  • participate
  • - Patient unable to understand the informed consent/study

Investigators

Similar Trials

Preoperative CT-imaging with... | Clinical Trial